CD9 AS A THERAPEUTIC TARGET FOR HEMATOLOGIC MALIGNANCIES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15653325

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method for detecting and treating hematologic malignancies including leukemia such as acute lymphoblastic leukemia (ALL) in a subject and a method for determining disease prognosis among leukemia patients by detecting CD9 expression. A kit and device useful for such methods are also provided. In addition, the present invention provides a composition for treating hematologic malignancies such as leukemia by suppressing CD9 expression or activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE CHINESE UNIVERSITY OF HONG KONGSHA TIN NEW TERRITORIES HONGKONG CHINA HONG KONG HONG KONG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chan, Yuen Yee Kathy Shatin, CN 1 0
Leung, Kam Tong Shatin, CN 1 0
Leung, Ting Fan Shatin, CN 3 0
Li, Chi Kong Shatin, CN 1 0
Li, Karen Shatin, CN 2 0
Ng, Pak Cheung Shatin, CN 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation